These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An immunologic basis for detection of occult primary malignancies of the head and neck. Coates HL, Pearson GR, Neel HB, Weiland LH, Devine KD. Cancer; 1978 Mar; 41(3):912-8. PubMed ID: 205337 [Abstract] [Full Text] [Related]
8. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma]. Amador García JM, Mendoza Montero J, Expósito Hernández J, Salinero Hernández J, Esquivias López-Cuerpo J, Ballesteros García P. Acta Otorrinolaringol Esp; 1992 Mar; 43(1):31-6. PubMed ID: 1316136 [Abstract] [Full Text] [Related]
9. Nasopharyngeal carcinoma and Epstein-Barr virus. II. Clinical course and the anti-VCA antibody. Lynn T, Tu S, Hirayama T, Kawamura A. Jpn J Exp Med; 1973 Apr; 43(2):135-44. PubMed ID: 4352112 [No Abstract] [Full Text] [Related]
13. Nasopharyngeal carcinoma and Epstein-Barr virus. I. Factors related to the anti-VCA antibody. Lynn T, Tu S, Hirayama T, Kawamura A. Jpn J Exp Med; 1973 Apr; 43(2):121-33. PubMed ID: 4352111 [No Abstract] [Full Text] [Related]
14. Epstein-Barr virus antibody titers in cancer of the head and neck. Callaghan DJ, Conner BR, Strauss M. Arch Otolaryngol; 1983 Dec; 109(12):781-4. PubMed ID: 6314955 [Abstract] [Full Text] [Related]
18. Anti-Epstein Barr virus antibody in nasopharyngeal carcinoma. Hsu MM, Chiou JF, McCabe BF. Ann Otol Rhinol Laryngol; 1974 Dec; 83(1):19-25. PubMed ID: 4359674 [No Abstract] [Full Text] [Related]
19. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan. Tamada A, Makimoto K, Yamabe H, Imai J, Hinuma Y, Oyagi A, Araki T. Cancer; 1984 Feb 01; 53(3):430-40. PubMed ID: 6318948 [Abstract] [Full Text] [Related]